)
Visual
test
Uniphar
Uniphar (UPR) investor relations material
Uniphar H2 2025 TU earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H2 2025 TU earnings summary27 Jan, 2026
Executive summary
Achieved approximately 21% adjusted EPS growth in 2025, surpassing expectations, driven by strong trading, organic gross profit growth, lower finance costs, and share buy-back accretion.
All divisions contributed to the fastest organic gross profit growth rate since IPO, with a six-year EPS CAGR of 16%.
Financial highlights
Organic gross profit grew by about 9% year-over-year in 2025.
Net Bank Debt/EBITDA was 1.5x at year-end, reflecting strong liquidity and favorable working capital movements.
€35m share buy-back program contributed to EPS accretion.
Outlook and guidance
Expects organic gross profit growth in 2026: double digit for Pharma, high single digit for Medtech, low single digit for Supply Chain & Retail.
Confident in reaching €200m EBITDA target by 2028, with at least 80% of growth being organic.
M&A remains a key growth strategy, with a disciplined approach to capital allocation and an active acquisition pipeline.
How will 80% organic growth for 2028 EBITDA be achieved?
Describe M&A pipeline and capital allocation
What drives Pharma's 2026 double-digit growth?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Latest summaries
- TimeTickerHeadlineOpen
- 5 FebGENI
A $1.2B deal creates a digital sports media powerhouse, boosting scale and profitability. - 5 FebMCFT
Q2 FY2026 sales up 13.2%, guidance raised, and $232M Marine Products deal to drive synergies. - 5 FebKLIC
Q1 2026 revenue up 20%, strong margins, robust Q2 outlook, and ongoing market risks. - 5 FebNSIT
Record Q4 profit and margin; 2026 guidance sees EPS growth and stable margins. - 5 FebITT
Record 2025 growth, strong cash flow, and positive 2026 outlook with SPX FLOW acquisition. - 5 FebROK
Double-digit sales and EPS growth drive raised 2026 guidance and strong segment performance. - 5 FebCLB
Q4 2025 revenue up 7% year-over-year; net debt and shares outstanding declined. - 5 FebBLSH
Record Q4 growth and options momentum set stage for strong 2026 expansion and tokenization. - 5 Feb2802
Record sales and profit highs, with raised full-year profit outlook and strong Q4 drivers. - 5 FebECB
Rates held steady as inflation nears 2% target; growth and reforms remain key priorities.
Next Uniphar earnings date
H2 202524 Feb, 2026
Uniphar
Next Uniphar earnings date
H2 202524 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Uniphar Public Limited Company is a diversified healthcare services provider, operating mainly in the Republic of Ireland, the United Kingdom, and on an international scale. The company functions through three primary divisions: Commercial & Clinical, Product Access, and Supply Chain & Retail. In the Commercial & Clinical segment, Uniphar offers outsourced sales, marketing, and multichannel account management services to pharmaco-medical manufacturers, alongside distribution and support services to medical device manufacturers. The Product Access division delivers services that facilitate access to pharmaco-medical products and treatments, establishing vital connections between manufacturers and healthcare stakeholders, as well as providing bespoke distribution partnerships for pharmaceutical partners. The Supply Chain & Retail division is involved in the pre-wholesale and wholesale distribution of pharmaceutical, healthcare, and animal health products to pharmacies, hospitals, and veterinary surgeons, and operates a network of pharmacies under various brands. Additionally, it provides a range of support services including pharmacy support, specialist nursing, infusion, medical device distribution, healthcare technology, data intelligence, consultancy, pharmaceutical advisory, medical affairs, online pharmacy, and product fostering services. The company is headquartered in Dublin, Ireland, and its shares are listed on the Irish Stock Exchange.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage